Test Predicts Response to Key Migraine Therapy With 86% Accuracy
Researchers from Harvard Medical School found non-ictal cephalic allodynia, established by a quick, inexpensive and noninvasive proprietary test, is an 86% accurate pretreatment predictor of anti-calcitonin gene–related peptide (CGRP) therapy response. To read the rest of the article head over to PainMedicineNews.com
More to explorer
Peptides: A promising alternative to opioids for chronic pain relief
A novel peptide for pain relief The researchers developed a novel peptide molecule that could prevent endocytosis to reduce the hyperactivity of
Top Celebrities Who’ve Had PRP Treatments
Facebook Our country wasn’t the first to adopt PRP. Kobe Bryant had to run to Germany to get his first PRP treatment.
Trial of Cooled Radiofrequency Ablation
Facebook Lumbar medial branch radiofrequency ablation (LRFA) and intraarticular facet steroid injections (FJI) are commonly performed for recalcitrant facet joint-mediated pain. However,